Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
e. coli strain m17 (2 trials)
Gastroesophageal Reflux (Phase 3)
Irritable Bowel Syndrome (Phase 2)
Syndrome (Phase 2)
Trials (2 total)
Trial APIs (1 total)